Drugs / Packed Red Blood Cells
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06462027 | Jun 2026 → Jul 2027 | cardiac arrest | NYU Langone Health | Suspended | No outcome recorded |
| Phase 1 | NCT05699005 | Sep 2023 → Mar 2028 expected | anemia, cardiogenic shock | University Hospital, Lille | Recruiting | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03981484 Comparator | Jan 2020 → Oct 2022 | blood coagulation disease, hemorrhagic disease | Bellal A. Joseph, MD, FACS | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04431999 Comparator | Dec 2021 → Oct 2025 | blood coagulation disease | Central Directorate of the Army Health Service | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07677150 Comparator | Oct 2026 → Sep 2028 expected | — | Medical University Innsbruck | Not yet recruiting | No outcome recorded |
| — | NCT02726620 Background | Jan → Dec 2017 | hypotensive disorder | Vanderbilt University Medical Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | packed red blood cells | “The later packs will consist of 3 packed red blood cells (PRBCs), 3 plasma units and 1 dose of platelets.” NCT04431999 ↗ |
| Known as | PRBC | “The purpose of this pilot interventional study is to collect preliminary data on administering packed red blood cell (PRBC) during cardiac arrest (CA).” NCT06462027 ↗ |
| Known as | PRBCs | “The later packs will consist of 3 packed red blood cells (PRBCs), 3 plasma units and 1 dose of platelets.” NCT04431999 ↗1“Packed Red Blood Cells (PRBCs)” NCT05699005 ↗ |
| Route | Intravenous | “500 mL of packed red blood cells administered intravenously 10-20 minutes after CA onset” NCT06462027 ↗ |